Comparative efficacy of long-acting bronchodilators for COPD: a network meta-analysis.
about
Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysisPharmacology of novel treatments for COPD: are fixed dose combination LABA/LAMA synergistic?Comparative safety and effectiveness of long-acting inhaled agents for treating chronic obstructive pulmonary disease: a systematic review and network meta-analysisComparative efficacy of combination bronchodilator therapies in COPD: a network meta-analysisUmeclidinium bromide/vilanterol combination in the treatment of chronic obstructive pulmonary disease: a reviewInterpreting patient-reported outcomes from clinical trials in COPD: a discussionA randomised, open-label study of umeclidinium versus glycopyrronium in patients with COPDInhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study.Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysisDiagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines.V0162 a new long-acting bronchodilator for treatment of chronic obstructive lung diseases: preclinical and clinical resultsEffects of indacaterol versus tiotropium on respiratory mechanics assessed by the forced oscillation technique in patients with chronic obstructive pulmonary disease.Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in SwedenComparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysis.LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis.A randomized, parallel-group study to evaluate the efficacy of umeclidinium/vilanterol 62.5/25 μg on health-related quality of life in patients with COPDCost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK.Comparative efficacy of long-acting β2-agonists as monotherapy for chronic obstructive pulmonary disease: a network meta-analysis.Umeclidinium/vilanterol as step-up therapy from tiotropium in patients with moderate COPD: a randomized, parallel-group, 12-week studyUpdate on ultra-long-acting β agonists in chronic obstructive pulmonary disease.Turning a molecule into a medicine: the development of indacaterol as a novel once-daily bronchodilator treatment for patients with COPD.Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary disease.Network Meta-analysis: Users' Guide for Surgeons: Part II - Certainty.Once-daily glycopyrronium bromide (Seebri Breezhaler(®)) for the treatment of chronic obstructive pulmonary disease (COPD).Recent advances in the management of chronic obstructive pulmonary disease.Aclidinium bromide inhalation powder for the long-term, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease including chronic bronchitis and emphysema.Antimicrobials for the treatment of drug-resistant Acinetobacter baumannii pneumonia in critically ill patients: a systemic review and Bayesian network meta-analysis.Emerging inhaled long-acting beta-2 adrenoceptor agonists for the treatment of COPD.Indacaterol for the treatment of chronic obstructive pulmonary disease.Tiotropium as part of inhaled polytherapy: adherence and associated health-care utilization.Cost-Effectiveness of Glycopyrronium Bromide Compared with Tiotropium in Patients with Chronic Obstructive Pulmonary Disease in Sweden.Muscarinic Receptor Antagonists.Olodaterol + tiotropium bromide for the treatment of COPD.Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysisDual bronchodilation vs triple therapy in the "real-life" COPD DACCORD study
P2860
Q24197853-0984B245-4CD3-4A52-A149-EECBBF025529Q26777927-5F623F2C-F3CA-4966-9420-592C1C638DD8Q26778794-4F90F26D-2CCE-4B61-A3BF-A98BF2196B28Q26782484-CE5A310A-FA6A-4CDA-8CD0-853AF225E573Q27015685-39F1AB29-20F4-402A-94CE-A2C2D0F0D683Q28072901-E1C29720-AF56-46B0-AE3C-F79FE0FFAF3DQ28596637-9A4F89D1-B266-4C8B-A17D-BE7E38ADB97EQ33766481-BC427EA4-B988-4905-9EE9-E0A086BB5561Q34471991-C787E85E-0268-45A4-9745-EB5159F17B2CQ35538249-28211A25-C51B-4AD9-A952-E51BE1C810E5Q35710238-7D3053BB-2C0A-483B-982C-29BD33364828Q35766357-E6FF3758-7967-43D6-A074-E9BF7592D480Q35964698-FFCFB24E-8FCA-42DC-83A2-8E4F07C5BFECQ36307097-14FBDE09-FBB3-4F21-A232-B85DAB1336BFQ36329064-55116A7B-113B-4BDA-9320-EB7D6CF757B5Q36907994-D6B1D834-8BF5-4DE5-AB1A-25A4D49E2142Q37012197-25879F97-16CB-400B-9C3B-C42113689D30Q37603579-AFD2C482-BF96-442D-914E-D1E398028076Q37682668-A7B6AC8E-4C64-40A0-B7F0-3E8A609CC22CQ38241442-3B7BB1D2-79D1-4832-9A31-6E7A383804C9Q38248438-12D5D78D-A6CF-423F-BCF8-2C573EBFE975Q38371305-D5F26913-0391-4E1B-AF68-3B464BFD62D4Q38418988-0392FC09-66A7-4F06-8AC4-294B9458FBA0Q38660895-DB186C05-24CC-4C4A-B7BE-2B55F71E23B9Q38701325-632E466F-D7A8-45BE-95D5-AB08C7F6FC65Q38783067-598A6EF4-B772-42E2-9684-DF42B432207DQ47143645-958E1EC6-7F6B-4AD2-8DDC-C4C0C69FF388Q47966525-DA94F02B-CFAD-4FB9-9A30-0514C155036BQ48059168-25F6F01C-25FE-4218-8DD9-5ADDB38A84A4Q50601223-17C3018B-3C9E-48DF-B1C5-48409D5DABDEQ51287554-AE4AB4FC-143A-4220-AA87-9C49BAED39C6Q51432583-974970FB-0943-4E7C-A3D2-A56DC2A609D9Q51545895-2C7F59C2-E21D-4CA0-80A9-9C29CA26BBABQ57817177-3AACEFB9-ED50-4F4D-B534-9EE84DFF6F92Q58706049-430B14FD-1A01-487D-9690-EE7D13E82913
P2860
Comparative efficacy of long-acting bronchodilators for COPD: a network meta-analysis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Comparative efficacy of long-acting bronchodilators for COPD: a network meta-analysis.
@en
Comparative efficacy of long-acting bronchodilators for COPD: a network meta-analysis.
@nl
type
label
Comparative efficacy of long-acting bronchodilators for COPD: a network meta-analysis.
@en
Comparative efficacy of long-acting bronchodilators for COPD: a network meta-analysis.
@nl
prefLabel
Comparative efficacy of long-acting bronchodilators for COPD: a network meta-analysis.
@en
Comparative efficacy of long-acting bronchodilators for COPD: a network meta-analysis.
@nl
P2093
P2860
P356
P1433
P1476
Comparative efficacy of long-acting bronchodilators for COPD: a network meta-analysis.
@en
P2093
Felicity Buckley
Gorana Capkun-Niggli
James F Donohue
Jeroen P Jansen
Matthias Kraemer
Michael Baldwin
Paul Jones
Shannon Cope
P2860
P2888
P356
10.1186/1465-9921-14-100
P577
2013-10-07T00:00:00Z
P5875
P6179
1017776251